{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:20:11Z","timestamp":1776489611826,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["PRE2019-088153"],"award-info":[{"award-number":["PRE2019-088153"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["FPU19\/03142"],"award-info":[{"award-number":["FPU19\/03142"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008441","name":"Ibero-American Program of Science and Technology for Development","doi-asserted-by":"publisher","award":["P219RT0008"],"award-info":[{"award-number":["P219RT0008"]}],"id":[{"id":"10.13039\/501100008441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","award":["2021 SGR 00698"],"award-info":[{"award-number":["2021 SGR 00698"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neurot.2024.e00439","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T07:42:57Z","timestamp":1725349377000},"page":"e00439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A combination of \u03949-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Nuria","family":"S\u00e1nchez-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"G\u00f3mez-Acero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Adell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Queir\u00f3z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Pedro","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e1tia R.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Rado\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Gasull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo A.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"K\u00f6falvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ciruela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Aso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2024.e00439_bib1","article-title":"2022 Alzheimer's disease facts and figures","volume":"18","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurot.2024.e00439_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.neurot.2024.e00439_bib3","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/S2666-7568(23)00193-9","article-title":"Evaluation of clinical benefits of treatments for Alzheimer's disease","volume":"4","author":"Liu","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.neurot.2024.e00439_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.neurot.2024.e00439_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/1389557516666161004162133","article-title":"Cannabis: a treasure trove or pandora's box?","volume":"17","author":"Solymosi","year":"2017","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.neurot.2024.e00439_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2018.08.016","article-title":"Cannabinoid pharmacology\/therapeutics in chronic degenerative disorders affecting the central nervous system","volume":"157","author":"Aymerich","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neurot.2024.e00439_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-160533","article-title":"Delineating the efficacy of a cannabis-based medicine at advanced stages of dementia in a murine model","volume":"54","author":"Aso","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neurot.2024.e00439_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u0394(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/JAD-150913","article-title":"Cannabinoid Receptor 2 Participates in amyloid-\u03b2 processing in a mouse model of Alzheimer's disease but plays a minor role in the therapeutic properties of a cannabis-based medicine","volume":"51","author":"Aso","year":"2016","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neurot.2024.e00439_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jnc.12304","article-title":"Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease","volume":"126","author":"Paula-Lima","year":"2013","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.neurot.2024.e00439_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuropharm.2013.08.026","article-title":"Predominant loss of glutamatergic terminal markers in a \u03b2-amyloid peptide model of Alzheimer's disease","volume":"76","author":"Canas","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2024.e00439_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hipo.22607","article-title":"Down-regulation of glutamatergic terminals (VGLUT1) driven by A\u03b2 in Alzheimer's disease","volume":"26","author":"Rodr\u00edguez-Perdig\u00f3n","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.neurot.2024.e00439_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurot.2024.e00439_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00439_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archneurol.2011.830","article-title":"Incidence of new-onset seizures in mild to moderate Alzheimer disease","volume":"69","author":"Irizarry","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurot.2024.e00439_bib18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2004.07.007","article-title":"On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures","volume":"68","author":"Lutz","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00439_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer's disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2024.e00439_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2024.e00439_bib22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00439_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1017\/S1461145708009267","article-title":"Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action","volume":"12","author":"L\u00f3pez-Gil","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41398-020-01110-y","article-title":"Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine","volume":"10","author":"Tarr\u00e9s-Gatius","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurot.2024.e00439_bib25","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.neurot.2024.e00439_bib26","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1975"},{"key":"10.1016\/j.neurot.2024.e00439_bib27","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.3390\/ijms24086968","article-title":"Downregulation of sirtuin 1 does not account for the impaired long-term potentiation in the prefrontal cortex of female APPswe\/PS1dE9 mice modelling Alzheimer's disease","volume":"24","author":"Lopes","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00439_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/35104061","article-title":"Dendritic spines: structure, dynamics and regulation","volume":"2","author":"Hering","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurot.2024.e00439_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuint.2016.05.009","article-title":"Neuronal vs glial glutamate uptake: resolving the conundrum","volume":"98","author":"Danbolt","year":"2016","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neurot.2024.e00439_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.03.001","article-title":"The molecular and systems biology of memory","volume":"157","author":"Kandel","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neurot.2024.e00439_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12017-009-8091-0","article-title":"Alzheimer's disease amyloid beta-protein and synaptic function","volume":"12","author":"Ondrejcak","year":"2010","journal-title":"NeuroMolecular Med"},{"key":"10.1016\/j.neurot.2024.e00439_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jnnp.2007.124149","article-title":"Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline","volume":"79","author":"Miller","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurot.2024.e00439_bib33","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1212\/WNL.0b013e3181e3966e","article-title":"Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline","volume":"74","author":"O'Brien","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2024.e00439_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71587-6","article-title":"Hippocampal alterations in glutamatergic signaling during amyloid progression in A\u03b2PP\/PS1 mice","volume":"10","author":"Hascup","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurot.2024.e00439_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2022.929474","article-title":"Friend or foe? Defining the role of glutamate in aging and Alzheimer's disease","volume":"3","author":"Cox","year":"2022","journal-title":"Front Aging"},{"key":"10.1016\/j.neurot.2024.e00439_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108758","article-title":"The tripartite glutamatergic synapse","volume":"199","author":"Lalo","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2024.e00439_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.20101","article-title":"Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice","volume":"55","author":"Trinchese","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2024.e00439_bib38","doi-asserted-by":"crossref","first-page":"12230","DOI":"10.1523\/JNEUROSCI.1694-14.2014","article-title":"Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid \u03b2","volume":"34","author":"Ma","year":"2014","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2024.e00439_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jnr.23378","article-title":"In vivo administration of granulocyte colony-stimulating factor restores long-term depression in hippocampal slices prepared from transgenic APP\/PS1 mice","volume":"92","author":"Song","year":"2014","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.neurot.2024.e00439_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-019-0670-1","article-title":"Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's disease","volume":"7","author":"Sri","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2024.e00439_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009764","article-title":"Synaptic plasticity in the hippocampus of a APP\/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice","volume":"5","author":"Gengler","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2024.e00439_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-170457","article-title":"Differences in synaptic dysfunction between rTg4510 and APP\/PS1 mouse models of alzheimer's disease","volume":"61","author":"Gelman","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neurot.2024.e00439_bib43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3390\/ijms22031378","article-title":"Impairment of spike-timing-dependent plasticity at schaffer collateral-CA1 synapses in adult APP\/PS1 mice depends on proximity of a\u03b2 plaques","volume":"22","author":"Garad","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2024.e00439_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/1759091419855541","article-title":"Amyloid beta-related alterations to glutamate signaling dynamics during Alzheimer's disease progression","volume":"11","author":"Findley","year":"2019","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neurot.2024.e00439_bib45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00439_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.neuron.2005.05.006","article-title":"Dendritic spine geometry: functional implication and regulation","volume":"46","author":"Hayashi","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2024.e00439_bib47","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1523\/JNEUROSCI.6142-10.2011","article-title":"Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease","volume":"31","author":"Perez-Cruz","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.neurot.2024.e00439_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00401-018-1847-6","article-title":"Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model","volume":"135","author":"Androuin","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2024.e00439_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ana.25049","article-title":"Dendritic spines provide cognitive resilience against Alzheimer's disease","volume":"82","author":"Boros","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2024.e00439_bib50","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/brain\/awv007","article-title":"Amyloid-\u03b2 deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression","volume":"138","author":"Huijbers","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2024.e00439_bib51","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/febs.15878","article-title":"Instructive roles of astrocytes in hippocampal synaptic plasticity: neuronal activity-dependent regulatory mechanisms","volume":"289","author":"Wang","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.neurot.2024.e00439_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108678","article-title":"CB1R-dependent regulation of astrocyte physiology and astrocyte-neuron interactions","volume":"195","author":"Covelo","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2024.e00439_bib53","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2024.e00439_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.962922","article-title":"Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease","volume":"16","author":"Coles","year":"2022","journal-title":"Front Neurosci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:10:05Z","timestamp":1762560605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1878747924001260"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00439","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combination of \u03949-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00439"}}